|
Market Closed -
Nasdaq
08:00:00 10/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 3.150 USD | +12.90% |
|
+3.28% | -72.96% |
| 07/11 | ARS Pharmaceuticals, Inc., Q3 2026 Earnings Call, Nov 05, 2026 | |
| 06/11 | Raymond James Downgrades ARS Pharmaceuticals to Outperform From Strong Buy, $17 Price Target | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SPRY | Delayed | |
CBOE
| SPRY | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 3.66 | 5.35 | 5.89 |
| Spread/Res. | -13.93% | -41.12% | -46.52% |
| Spread/Supp. | +18.87% | +18.87% | +25.55% |
| Support | 2.65 | 2.65 | 2.509 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- SPRY Stock
- Charts ARS Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
